Related Experiment Video
Updated: Jan 26, 2026

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
Published on: December 9, 2016
Targeting the Temporal Dynamics of Hypoxia-Induced Tumor-Secreted Factors Halts Tumor Migration
Manjulata Singh1, Xiao-Jun Tian2,3, Vera S Donnenberg1,4
1Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania.
Abstract:
Targeting microenvironmental factors that foster migratory cell phenotypes is a promising strategy for halting tumor migration. However, lack of mechanistic understanding of the emergence of migratory phenotypes impedes pharmaceutical drug development. Using our three-dimensional microtumor model with tight control over tumor size, we recapitulated the tumor size-induced hypoxic microenvironment and emergence of migratory phenotypes in microtumors from epithelial breast cells and patient-derived primary metastatic breast cancer cells, mesothelioma cells, and lung cancer xenograft cells. The microtumor models from various patient-derived tumor cells and patient-derived xenograft cells revealed upregulation of tumor-secreted factors, including matrix metalloproteinase-9 (MMP9), fibronectin (FN), and soluble E-cadherin, consistent with clinically reported elevated levels of FN and MMP9 in patient breast tumors compared with healthy mammary glands. Secreted factors in the conditioned media of large microtumors induced a migratory phenotype in nonhypoxic, nonmigratory small microtumors. Subsequent mathematical analyses identified a two-stage microtumor progression and migration mechanism whereby hypoxia induces a migratory phenotype in the initialization stage, which then becomes self-sustained through a positive feedback loop established among the tumor-secreted factors. Computational and experimental studies showed that inhibition of tumor-secreted factors effectively halts microtumor migration despite tumor-to-tumor variation in migration kinetics, while inhibition of hypoxia is effective only within a time window and is compromised by tumor-to-tumor variation, supporting our notion that hypoxia initiates migratory phenotypes but does not sustain it. In summary, we show that targeting temporal dynamics of evolving microenvironments, especially tumor-secreted factors during tumor progression, can halt tumor migration. SIGNIFICANCE: This study uses state-of-the-art three-dimensional microtumor models and computational approaches to highlight the temporal dynamics of tumor-secreted microenvironmental factors in inducing tumor migration.
Insights
Targeting tumor-secreted factors halts cancer cell migration by disrupting a self-sustaining feedback loop. This approach is more effective than targeting hypoxia, offering a promising strategy for drug development.
Area of Science:
- Oncology
- Cell Biology
- Biophysics
Background:
- Tumor migration is a critical step in metastasis, yet the mechanisms driving migratory phenotypes remain incompletely understood, hindering drug development.
- Microenvironmental factors, such as hypoxia, are known to influence tumor behavior, but their precise role in initiating and sustaining migration requires further elucidation.
Purpose of the Study:
- To investigate the mechanistic basis of tumor size-induced migratory phenotypes using a novel 3D microtumor model.
- To identify key tumor-secreted factors involved in promoting cell migration and to evaluate therapeutic strategies targeting these factors or hypoxia.
Main Methods:
- Development and utilization of a 3D microtumor model allowing control over tumor size and microenvironment.
- Analysis of tumor-secreted factors (e.g., MMP9, FN) and their role in inducing migratory phenotypes.
- Mathematical modeling to elucidate the temporal dynamics of tumor progression and migration.
- Experimental validation of therapeutic interventions targeting secreted factors and hypoxia.
Main Results:
- Tumor size-induced hypoxia recapitulated migratory phenotypes in various cancer cell types.
- Upregulation of tumor-secreted factors like MMP9 and FN was observed, correlating with clinical findings.
- A two-stage mechanism was identified: hypoxia initiates migration, which is then sustained by a positive feedback loop of secreted factors.
- Inhibition of tumor-secreted factors effectively halted migration, whereas hypoxia inhibition showed limited efficacy and high variability.
Conclusions:
- Tumor migration is driven by a temporal interplay between hypoxia-induced initiation and self-sustained positive feedback loops of secreted factors.
- Targeting tumor-secreted factors represents a robust therapeutic strategy to halt tumor migration, overcoming inter-tumor heterogeneity.
- Understanding the temporal dynamics of the tumor microenvironment is crucial for developing effective anti-metastatic therapies.
Related Concept Videos
Tumor Immunotherapy
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

